According to HTG Molecular Diagnostics 's latest financial reports and stock price the company's current number of shares outstanding is 2,214,082. At the end of 2023 the company had 2,214,082 shares outstanding. The number of outstanding shares is usually impacted by stock plits and shares buy back.
Year | Shares Outstanding | Change |
---|---|---|
2023 | 2.21 M | 140.48% |
2022 | 0.92 M | -87.63% |
2021 | 7.44 M | 54.31% |
2020 | 4.82 M | -84.63% |
2019 | 31.36 M | 10.31% |
2018 | 28.43 M | 119.08% |
2017 | 12.97 M | 73.32% |
2016 | 7.48 M | 9.47% |
2015 | 6.84 M | 1952.11% |
2014 | 0.33 M |
Company | Shares Outstanding | differencediff. | Country |
---|---|---|---|
Lexicon Pharmaceuticals
LXRX | 244,925,000 | 10,962.15% | ๐บ๐ธ USA |
Affimed
AFMD | 14,933,933 | 574.50% | ๐ฉ๐ช Germany |
Calithera Biosciences
CALA | 4,865,000 | 119.73% | ๐บ๐ธ USA |